Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biotech
biotech
The 2023 Biotech Graveyard
Fierce Biotech
Tue, 10/31/23 - 11:34 am
biotech
Rubius Therapeutics
Nabriva Therapeutics
Calithera Biosciences
Goldfinch Bio
Antios Therapeutics
Magenta Therapeutics
Coda Biotherapeutics
Aristea Therapeutics
Lessons from a biotech downturn: Funding challenges, an IPO dry spell and what to expect in 2024
BioPharma Dive
Fri, 10/27/23 - 11:39 am
biotech
funding
IPOs
'By hook or by crook': BIO CEO urges biotechs to be flexible on funding to survive tough times
Fierce Biotech
Wed, 10/25/23 - 11:05 am
BIO
biotech
funding
Inflation Reduction Act
Biotech Accelerator Debuts in Houston
BioSpace
Thu, 10/19/23 - 10:01 am
biotech
accelerators
Houston
Texas
Rice University
A decade later, biotech’s CRISPR revolution is still going strong
BioPharma Dive
Thu, 10/12/23 - 05:14 pm
CRISPR
gene editing
biotech
Massachusetts Biopharma Job Growth Surpasses that of Other States: Report
BioSpace
Thu, 10/12/23 - 11:42 am
Massachusetts
R&D
biotech
biotech hubs
Biotech Bankruptcies Skyrocket
BioSpace
Wed, 10/11/23 - 10:35 am
biotech
bankruptcy
Athenex
Aceragen
Avadel Specialty Pharmaceuticals
NephroGenex
Sancilio Pharmaceuticals
Statera Biopharma
After pandemic sugar rush, a market 'hangover' opens biotech to funding approaches steeped in stigma
Fierce Biotech
Mon, 10/9/23 - 11:17 am
biotech
funding
venture capital
How biotech IPOs performed in the third quarter
BioPharma Dive
Tue, 10/3/23 - 10:28 am
biotech
IPOs
Adlai Nortye
RayzeBio
Neumora Therapeutics
Mira Pharmaceuticals
Turnstone Biologics
Apogee Therapeutics
Sagimet Biosciences
60 Degrees Pharma
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
BioSpace
Sun, 09/17/23 - 09:45 pm
biotech
IPOs
Neumora Therapeutics
Rome Therapeutics
Generate Biomedicines
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
‘It’s Like Ross Was Planning This Project.’ Perot Sr.’s HQ Finds New Life as Biotech Development
D Magazine
Thu, 08/31/23 - 11:48 am
biotech
Texas
NexPoint
Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Stat
Thu, 08/24/23 - 10:25 am
Vivek Ramaswamy
2024 Presidential election
biotech
Roivant
Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?
Forbes
Wed, 08/23/23 - 11:02 am
biotech
layoffs
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Stat
Wed, 08/9/23 - 10:19 am
biotech
funding
venture capital
The Column Group
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Stat
Tue, 08/8/23 - 10:19 am
biotech
funding
venture capital
Biopharma sector still growing despite layoff wave, Stifel report finds
BioPharma Dive
Mon, 08/7/23 - 11:17 pm
biopharma
biotech
jobs
layoffs
Early-stage biotech funding on pace to drop 40% in 2023, HSBC report shows
BioPharma Dive
Sat, 07/29/23 - 10:48 pm
biotech
funding
HSBC
Biophama's flotation haul creeps higher
EP Vantage
Thu, 07/6/23 - 10:09 am
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
Women left out of VC club fight for their identity, pulling each other up one by one
Fierce Biotech
Wed, 06/7/23 - 10:05 am
venture capital
biotech
funding
Norwest Venture Partners
women
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »